Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype-Reference-Cited by-同舟云学术

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype

Published:2015-12-09 Issue:1 Volume:155 Page:85-97
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Schroth Werner,Winter S.,Büttner F.,Goletz S.,Faißt S.,Brinkmann F.,Saladores P.,Heidemann E.,Ott G.,Gerteis A.,Alscher M. D.,Dippon J.,Schwab M.,Brauch H.,Fritz P.

Funder

Robert Bosch Stiftung

Deutsche Forschungsgemeinschaft

Marie Curie Initial Training Network FightingDrugFailure

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3651-5.pdf

Reference51 articles.

1. McGuire WL (1973) Estrogen receptors in human breast cancer. J Clin Invest 52:73–77. doi: 10.1172/JCI107175

2. Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669–4671

3. Ruder AM, Lubin F, Wax Y et al (1989) Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences. Cancer 64:196–202. doi: 10.1002/1097-0142(19890701)64:1<196:AID-CNCR2820640134>3.0.CO;2-3

4. Aaltomaa SS, Lipponen PP, Eskelinen MM et al (1991) Hormone receptors as prognostic factors in female breast cancer. Ann Med 23:643–648. doi: 10.3109/07853899109148097

5. Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987–4991

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy;Diagnostic Pathology;2024-01-04

2. Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy;2023-10-12

3. Hormone receptors in breast cancer: An update on the uncommon subtypes;Pathology - Research and Practice;2023-10

4. Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+);Frontiers in Endocrinology;2023-07-19

5. A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer;Breast Cancer Research and Treatment;2023-05-18